ENXTPA:SAN
ENXTPA:SANPharmaceuticals

Sanofi (ENXTPA:SAN) Gains Orphan Drug Status In Japan For CIDP Treatment

Sanofi (ENXTPA:SAN) recently received orphan drug designation from Japan's Ministry of Health for riliprubart, aimed at treating chronic inflammatory demyelinating polyneuropathy. This underscores the company's focus on expanding treatment options for underserved patient populations. Despite this positive development, Sanofi's share price experienced little change in the past week. While the market indices such as the S&P 500 and Nasdaq achieved record highs, bolstered by easing geopolitical...
ENXTPA:AIR
ENXTPA:AIRAerospace & Defense

3 European Stocks Estimated To Be Up To 48.6% Undervalued Offering A 29.9% Discount Opportunity

As European markets grapple with geopolitical tensions and economic uncertainties, the pan-European STOXX Europe 600 Index recently declined by 1.54%, reflecting broader concerns in the region. In this environment, identifying undervalued stocks can provide investors with potential opportunities to capitalize on market inefficiencies, especially when these stocks are trading at significant discounts relative to their intrinsic value.